{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:15:53Z","timestamp":1787739353785,"version":"build-2784847793"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jceh.2021.01.006","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T11:43:06Z","timestamp":1612525386000},"page":"691-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gilbert's Syndrome, Bilirubin Level and UGT1A1\u221728 Genotype in Men of North-West Region of Russia"],"prefix":"10.1016","volume":"11","author":[{"given":"Andrei","family":"Ivanov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Semenova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2021.01.006_bib1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4439(98)00044-1","article-title":"Biochemical and molecular aspects of genetic disorders of bilirubin metabolism","volume":"1407","author":"Iyanagi","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jceh.2021.01.006_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2353\/jmoldx.2008.080036","article-title":"Rapid allelic discrimination by taqman pcr for the detection of the gilbert's syndrome marker UGT1A1\u221728","volume":"10","author":"Ehmer","year":"2008","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.jceh.2021.01.006_bib3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/07853890.2014.895588","article-title":"Effects of serum bilirubin on atherosclerotic processes","volume":"46","author":"Kang","year":"2014","journal-title":"Ann Med"},{"key":"10.1016\/j.jceh.2021.01.006_bib4","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1038\/s41598-018-19847-4","article-title":"\u201cGilbert\u2019s-like\u201d syndrome as part of a spectrum of persistent unconjugated hyperbilirubinemia in post-chronic hepatitis patients","volume":"8","author":"Ye","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jceh.2021.01.006_bib5","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1086\/466531","article-title":"Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia","volume":"192","author":"Rotger","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.jceh.2021.01.006_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00431-011-1641-0","article-title":"Gilbert syndrome","volume":"171","author":"Fretzayas","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jceh.2021.01.006_bib7","first-page":"25","article-title":"Frequency of the UGT1A1\u221728 polymorphism in a Romanian cohort of gilbert syndrome individuals","volume":"26","author":"Radoi","year":"2017","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"key":"10.1016\/j.jceh.2021.01.006_bib8","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/clinchem\/46.12.1939","article-title":"DNA base bulge vs unmatched end formation in probe-based diagnostic insertion\/deletion genotyping: genotyping the UGT1A1 (TA)(n) polymorphism by real-time fluorescence PCR","volume":"46","author":"von Ahsen","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.jceh.2021.01.006_bib9","doi-asserted-by":"crossref","first-page":"8719","DOI":"10.1074\/jbc.273.15.8719","article-title":"Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8","volume":"273","author":"Strassburg","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jceh.2021.01.006_bib10","doi-asserted-by":"crossref","first-page":"8170","DOI":"10.1073\/pnas.95.14.8170","article-title":"Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?","volume":"95","author":"Beutler","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jceh.2021.01.006_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000442042","article-title":"UGT1A1\u221728 Genotypes and respiratory disease in very preterm infants: a cohort study","volume":"109","author":"Petersen","year":"2016","journal-title":"Neonatology"},{"key":"10.1016\/j.jceh.2021.01.006_bib12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1158\/1055-9965.EPI-03-0070","volume":"13","author":"Fang","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jceh.2021.01.006_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077681","article-title":"The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients","volume":"8","author":"AlFadhli","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jceh.2021.01.006_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-230X-10-57","article-title":"Combined effect of regulatory polymorphisms on transcription of UGT1A1 as a cause of Gilbert syndrome","volume":"10","author":"Matsui","year":"2010","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jceh.2021.01.006_bib15","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00439-004-1183-x","article-title":"Two linked polymorphic mutations (A (TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome","volume":"115","author":"Maruo","year":"2004","journal-title":"Hum Genet"},{"key":"10.1016\/j.jceh.2021.01.006_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/FPC.0000000000000024","article-title":"PharmGKB summary: very important pharmacogene information for UGT1A1","volume":"24","author":"Barbarino","year":"2014","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jceh.2021.01.006_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10408363.2018.1428526","article-title":"Diagnostic criteria and contributors to Gilbert's syndrome","volume":"55","author":"Wagner","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.jceh.2021.01.006_bib18","first-page":"32","article-title":"Features of Gilbert's syndrome in patients with different genotypes UGT1A1","volume":"133","author":"Kurilovich","year":"2016","journal-title":"Eksperimental\u2019naya i Klinicheskaya Gastroenterologiya"},{"key":"10.1016\/j.jceh.2021.01.006_bib19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.21668\/health.risk\/2019.2.14.eng","article-title":"UGT1A1 gene mutation as a marker indicating there is a high risk of Gilbert's syndrome: theoretical and applied aspects","volume":"2","author":"Volkov","year":"2019","journal-title":"Health risk analysis"},{"key":"10.1016\/j.jceh.2021.01.006_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/pr.2016.75","article-title":"Contribution of UGT1A1 variations to chemotherapy-induced unconjugated hyperbilirubinemia in pediatric leukemia patients","volume":"80","author":"Nomura","year":"2016","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jceh.2021.01.006_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006306","article-title":"UGT1A1\u221728 relationship with abnormal total bilirubin levels in chronic hepatitis C patients","volume":"96","author":"de Souza","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.jceh.2021.01.006_bib22","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(96)91273-8","article-title":"Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome","volume":"347","author":"Monaghan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2021.01.006_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bcmd.2012.01.004","article-title":"Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects","volume":"48","author":"Rodrigues","year":"2012","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jceh.2021.01.006_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rce.2016.10.001","article-title":"Genetic susceptibility to Gilbert's syndrome in a Valencian population; efficacy of the fasting test","volume":"217","author":"Torres","year":"2017","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.jceh.2021.01.006_bib25","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/jhep.2000.18193","article-title":"Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects","volume":"32","author":"Borlak","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.01.006_bib26","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2215\/CJN.06130710","article-title":"Serum bilirubin links UGT1A1\u221728 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients","volume":"6","author":"Chen","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jceh.2021.01.006_bib27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3892\/ol.2014.2767","article-title":"Congenital absence of the portal vein associated with focal nodular hyperplasia of the liver and congenital heart disease (Abernethy malformation): a case report and literature review","volume":"9","author":"Hao","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jceh.2021.01.006_bib28","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/liv.12141","article-title":"Gallstone disease in Swedish twins is associated with the Gilbert variant of UGT1A1","volume":"33","author":"Marschall","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2021.01.006_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3350\/kjhep.2010.16.3.321","article-title":"A\u00a0case of concomitant Gilbert's syndrome and hereditary spherocytosis","volume":"16","author":"Lee","year":"2010","journal-title":"Korean J Hepatol"},{"key":"10.1016\/j.jceh.2021.01.006_bib30","first-page":"950","article-title":"Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans","volume":"60","author":"Guillemette","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jceh.2021.01.006_bib31","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1134\/S0026893306020075","article-title":"Association of SULT1A1 and UGT1A1 polymorphisms with breast cancer risk and phenotypes in Russian women","volume":"40","author":"Shatalova","year":"2006","journal-title":"Mol Biol"},{"key":"10.1016\/j.jceh.2021.01.006_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cancergen.2012.01.015","article-title":"Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer","volume":"205","author":"Bajro","year":"2012","journal-title":"Cancer Genet"},{"key":"10.1016\/j.jceh.2021.01.006_bib33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.mehy.2011.03.047","article-title":"Is Gilbert syndrome a new risk factor for breast cancer?","volume":"77","author":"Astolfi","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.jceh.2021.01.006_bib34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4292\/wjgpt.v7.i4.469","article-title":"Bilirubin in coronary artery disease: cytotoxic or protective? World","volume":"7","author":"Gupta","year":"2016","journal-title":"J\u00a0Gastrointest Pharmacol Ther"},{"key":"10.1016\/j.jceh.2021.01.006_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0021-9150(01)00601-3","article-title":"Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels","volume":"160","author":"Vitek","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jceh.2021.01.006_bib36","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/phar.1946","article-title":"Oncology drug dosing in gilbert syndrome associated with UGT1A1: a summary of the literature","volume":"37","author":"Ha","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jceh.2021.01.006_bib37","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1158\/1055-9965.EPI-07-2517","article-title":"Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk","volume":"17","author":"Lankisch","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jceh.2021.01.006_bib38","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2217\/pgs-2016-0063","article-title":"Polymorphisms in SLCO1B1 and UGT1A1 are associated with sorafenib-induced toxicity","volume":"17","author":"Bins","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jceh.2021.01.006_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/jcph.625","article-title":"Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48-hour continuous infusion in patients with cancer","volume":"56","author":"Goey","year":"2016","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jceh.2021.01.006_bib40","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/hep.21361","article-title":"Gilbert's disease and atazanavir: from phenotype to UDP-glucuronosyltransferase haplotype","volume":"44","author":"Lankisch","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2021.01.006_bib41","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.2147\/OTT.S95149","article-title":"The relationship between UGT1A1 gene polymorphism and irinotecan effect on extensive-stage small-cell lung cancer","volume":"8","author":"Xiao","year":"2015","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jceh.2021.01.006_bib42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00280-016-3057-z","article-title":"UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer","volume":"78","author":"Xu","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jceh.2021.01.006_bib43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2133\/dmpk.DMPK-14-RG-031","article-title":"Influence of UGT1A1 6, 27, and 28 polymorphisms on nilotinib-induced hyperbilirubinemia in Japanese patients with chronic myeloid leukemia","volume":"29","author":"Abumiya","year":"2014","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.jceh.2021.01.006_bib44","doi-asserted-by":"crossref","first-page":"19579","DOI":"10.7448\/IAS.17.4.19579","article-title":"Clinical significance of the UGT1A1\u221728 allele detection in HIV-infected patients","volume":"17","author":"Kanestri","year":"2014","journal-title":"J\u00a0Int AIDS Soc"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321000220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688321000220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:06:35Z","timestamp":1760853995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688321000220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0973688321000220"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2021.01.006","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gilbert's Syndrome, Bilirubin Level and UGT1A1\u221728 Genotype in Men of North-West Region of Russia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2021.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}